Evidence map›Paper›PMID 40557798›Full record

ArticleJournal of the American Heart Association2025

Heart Disease Mortality in the United States, 1970 to 2022.

Sara J King, Tenzin Yeshi Wangdak Yuthok, Adrian M Bacong, Abha Khandelwal, Dhruv S Kazi, Michael E Mussolino, Sally S Wong, Seth S Martin, Eldrin F Lewis, Fatima Rodriguez and 1 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Third Year in Review, Fourth Year in Preview, and the 2025Journal of the American Heart Association · 2026
    Article
  14. Research Priorities and Future Directions in Cardio-Oncology.Current treatment options in oncology · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The success-failure inversion in modern medicine.Frontiers in public health · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sara J KingDepartment of Medicine Stanford University School of Medicine Stanford CA USA.ORCID 0000-0002-8971-1655
Tenzin Yeshi Wangdak YuthokDepartment of Medicine Stanford University School of Medicine Stanford CA USA.ORCID 0000-0002-1087-8031
Adrian M BacongDivision of Cardiovascular Medicine and the Cardiovascular Institute, Center for Academic Medicine Stanford Universitsy School of Medicine Stanford CA USA.ORCID 0000-0003-0157-4754
Abha KhandelwalDivision of Cardiovascular Medicine and the Cardiovascular Institute, Center for Academic Medicine Stanford Universitsy School of Medicine Stanford CA USA.
Dhruv S KaziRichard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-9510-2979
Michael E MussolinoNational Heart, Lung, and Blood Institute National Institutes of Health Bethesda MD USA.
Sally S WongAmerican Heart Association, Office of Science, Medicine and Health Dallas TX USA.
Seth S MartinCiccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology Johns Hopkins University School of Medicine Baltimore MD USA.ORCID 0000-0002-7021-7622
Eldrin F LewisDivision of Cardiovascular Medicine and the Cardiovascular Institute, Center for Academic Medicine Stanford Universitsy School of Medicine Stanford CA USA.
Fatima RodriguezDivision of Cardiovascular Medicine and the Cardiovascular Institute, Center for Academic Medicine Stanford Universitsy School of Medicine Stanford CA USA.ORCID 0000-0002-5226-0723
Latha P PalaniappanDivision of Cardiovascular Medicine and the Cardiovascular Institute, Center for Academic Medicine Stanford Universitsy School of Medicine Stanford CA USA.ORCID 0000-0002-1245-665X

Funding

Diabetes, Endocrinology and Metabolism Training GrantT32DK007217 · NIDDK · STANFORD UNIVERSITY · PI Justin Pierce Annes, David Matthew Maahs · 1987 to 2026
$7.2M
Opportunistic Atherosclerotic Cardiovascular Disease Risk Estimation at Abdominal CTs with Robust and Unbiased Deep LearningR01HL167974 · NHLBI · STANFORD UNIVERSITY · PI Imon Banerjee, Akshay Chaudhari · 2023 to 2026
$2.4M
Novel Incidental Calcium Evaluation (NICE)R01HL169345 · NHLBI · STANFORD UNIVERSITY · PI Imon Banerjee, Akshay Chaudhari · 2024 to 2026
$2.1M
Adherence Determinants in the Health Electronic Record Evaluation of Statins (ADHERES)R01HL168188 · NHLBI · STANFORD UNIVERSITY · PI Fatima Rodriguez · 2024 to 2026
$2.1M
SURPASS: (Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in minority Subgroups)K01HL144607 · NHLBI · STANFORD UNIVERSITY · PI RODRIGUEZ, FATIMA · 2019 to 2023
$856k
META - Mentor, Educate, Train, Advocate: Patient Oriented Researchers in Cardiometabolic DiseaseK24HL150476 · NHLBI · STANFORD UNIVERSITY · PI Latha P Palaniappan · 2020 to 2026
$846k
NHLBI NIH HHS K01 HL144607NHLBI NIH HHS K24 HL150476NHLBI NIH HHS R01 HL167974NHLBI NIH HHS R01 HL168188NHLBI NIH HHS R01 HL169345NIDDK NIH HHS T32 DK007217
6 · The paper itself

Abstract

backgroundStudying trends in mortality is essential to advance understanding of population health. Further evaluation of long-term heart disease mortality trends and subtypes in the United States is needed to guide public health and clinical interventions.

methodsThis study used the National Vital Statistics System Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research data for adults aged 25 years and older in the United States from 1970 to 2022. Outcomes included absolute number and age-adjusted mortality of total heart disease, ischemic heart disease, and other heart disease subtypes.

resultsFrom 1970 to 2022, overall age-adjusted heart disease mortality decreased by 66% from 1970 to 2022 (from 761 to 258 per 100 000). In 1970, 91% of all heart disease deaths were ischemic, declining to 53% of all heart disease deaths in 2022. From 1970 to 2022, age-adjusted mortality decreased by 89% for acute myocardial infarction (from 354 to 40 per 100 000) and 81% for all ischemic heart disease (from 693 to 135 per 100 00). In contrast, from 1970 to 2022 age-adjusted mortality for other heart disease subtypes increased by 81% (from 68 to 123 per 100 000), with the greatest increases in heart failure (146% increase), hypertensive heart disease (106% increase) and arrhythmias (450% increase).

conclusionsHeart disease mortality has decreased over the past 5 decades. There is an increasing burden of mortality from other heart conditions including heart failure, hypertensive heart disease, and arrhythmias. Further efforts must be undertaken to address the growing challenge of these other heart conditions.

Indexed as

Heart DiseasesAdultAgedAged, 80 and overCause of DeathFemaleHumansMaleMiddle AgedMortalityUnited Statesheart diseaseischemicmortality

Identifiers

PMID40557798
PMCPMC12449979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.